ArticleScientific reports2025
Transparent AI-driven personalized risk prediction system for acute kidney injury after total hip arthroplasty.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-driven nanomedicine for cancer theranostics.Molecular cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury is a common and severe complication following total hip arthroplasty, particularly in elderly or high-risk patients with chronic conditions, significantly increasing morbidity and mortality rates. Traditional prediction methods often struggle with the complexity of multidimensional healthcare data. To address this, we developed a machine learning-based prediction model using multidimensional data from 4601 total hip arthroplasty patients, encompassing 16 general variables (e.g., demographic characteristics, surgical duration, and hospital stay) and 53 laboratory indicators (e.g., Cystatin C, D-dimer, and glucose). Feature selection was performed using Random Forest, Lasso regression, and mutual information analysis, with clinically relevant features such as Cystatin C, glucose, and N-terminal proBNP retained to enhance model interpretability and predictive power. To address class imbalance, we applied the Synthetic Minority Over-sampling Technique and Edited Nearest Neighbors. Among multiple models, CatBoost achieved the best performance, with an area under the receiver operating characteristic curve of 0.95 (95% CI 0.93-0.96), an accuracy of 0.88 (95% CI 0.85-0.90), and an F1-score of 0.79 (95% CI 0.75-0.84) in the internal validation set. External validation using an independent hospital dataset (n = 240) further confirmed the model's robustness, with an AUC of 0.65 (95% CI 0.57-0.73). However, the substantial performance decline in external validation underscores the need for cautious interpretation of performance metrics and institution-specific validation prior to clinical deployment. Shapley Additive Explanations analysis identified Cystatin C, surgical duration, and creatinine as key predictors, demonstrating the model's transparency and clinical relevance. A real-time prediction system, developed using the Flask framework, was validated externally, confirming its utility for acute kidney injury risk assessment and personalized postoperative management. These findings highlight the model's potential to improve clinical decision-making and outcomes for high-risk patients undergoing total hip arthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.